A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional ...
4 hours ago
0
65
A deeper understanding of the immune system's role in controlling cancer has helped drive "an immunotherapy revolution," offering hope for many patients with previously incurable cancers, including children, doctors have ...
The discovery of tri-specific natural killer engagers (TriKE), a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing power exponentially, has led to a new Phase I, first-in-human study ...
Sep 19, 2019
0
2
(HealthDay)—Many older patients with acute myeloid leukemia (AML) do not receive any active treatment, and they have worse survival than those receiving active treatment, according to a study published online Sept. 4 in ...
Sep 18, 2019
0
1
Dear Mayo Clinic: Who can be a bone marrow donor? What's the process for becoming one?
Sep 19, 2019
0
0
Researchers have discovered a potential drug target for Alzheimer's disease—an enzyme which has effects on both the immune and nervous systems.
Sep 19, 2019
0
9
T-cell ProLymphocytic leukemia (T-PLL) is the most aggressive of all known forms of leukemia. Although many cancer drugs are now available, therapeutic success is limited for T-PLL patients. Until now, no international studies ...
Sep 02, 2019
0
3
A novel CAR T-cell therapy, developed by UCL researchers and designed to target cancer cells more quickly and cause fewer side effects, has shown very promising results for children with previously incurable acute lymphoblastic ...
Sep 04, 2019
0
357
UCSF Benioff Children's Hospitals have successfully treated a months-old infant with a rare childhood leukemia using a targeted therapy approved for adults with inoperable liver cancer and advanced kidney cancer.
Sep 12, 2019
0
1
Scientists from the National Institutes of Health and Cincinnati Children's Hospital Medical Center have devised a potential treatment against a common type of leukemia that could have implications for many other types of ...
Sep 04, 2019
0
156
CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients' own cells to treat certain types of cancers, may be a viable treatment option for another life-threatening condition: heart disease. In a first-of-its-kind ...
Sep 11, 2019
0
63
(HealthDay)—Cancer takes a huge emotional toll on patients, but a new study finds the financial costs are also so high that many are resorting to crowdfunding to help pay their medical bills and related costs.
Sep 10, 2019
0
1
Sonia Guil, leader of the Regulatory and Chromatin RNA group of Josep Carreras Leukemia Research Institute, and Lourdes Farré of ProCURE (Idibell) have discovered an intermediate molecule expressed from a region of the non-coding ...
Sep 04, 2019
0
9
More than 30 million Americans suffer from diabetes and must inject themselves with insulin two to four times daily. Researchers have been looking for ways to administer the drug orally, and researchers at Carnegie Mellon ...
Aug 29, 2019
0
3
Blocking a kinase known as CDK7 sets off a chain reaction that results in the death of prostate cancer cells that have spread and are resistant to standard therapies, according to a new study from researchers in the Abramson ...
Aug 29, 2019
0
7
Leukemia (American English) or leukaemia (British English) (from the Greek leukos λεύκος - white, and haima αίμα - blood) is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader group of diseases affecting the blood, bone marrow, heart, and lymphoid system, which are all known as hematological neoplasms. Leukemia can also cause multiple organ failure.
In 2000, approximately 256,000 children and adults around the world developed some form of leukemia, and 209,000 died from it.[citation needed]
This text uses material from Wikipedia licensed under CC BY-SA
